# Escitalopram as a Mood Stabilizer for Bipolar II Disorder

> **NCT00156325** · PHASE2 · COMPLETED · sponsor: **The University of New South Wales** · enrollment: 10 (—)

## Conditions studied

- Bipolar Disorders

## Interventions

- **DRUG:** Escitalopram (Lexapro)

## Key facts

- **NCT ID:** NCT00156325
- **Lead sponsor:** The University of New South Wales
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 10 (—)
- **Last updated:** 2006-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156325, "Escitalopram as a Mood Stabilizer for Bipolar II Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00156325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*